ZLAB Zai Lab Ltd

USD 16.19 0.24 1.504702
Icon

Zai Lab Ltd (ZLAB) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 16.19

+0.24 (+1.50)%

USD 1.61B

1.04M

USD 62.71(+287.34%)

USD 0.00 (-100.00%)

Icon

ZLAB

Zai Lab Ltd (USD)
COMMON STOCK | NSD
USD 16.19
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.61B

USD 0.00 (-100.00%)

USD 16.19

Zai Lab Ltd (ZLAB) Stock Forecast

Show ratings and price targets of :
USD 62.71
(+287.34%)

Based on the Zai Lab Ltd stock forecast from 3 analysts, the average analyst target price for Zai Lab Ltd is USD 62.71 over the next 12 months. Zai Lab Ltd’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Zai Lab Ltd is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Zai Lab Ltd’s stock price was USD 16.19. Zai Lab Ltd’s stock price has changed by -5.93% over the past week, -28.01% over the past month and -50.40% over the last year.

No recent analyst target price found for Zai Lab Ltd
No recent average analyst rating found for Zai Lab Ltd

Company Overview Zai Lab Ltd

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields t...Read More

Jinchuang Plaza, Shanghai, China, 201210

2,175

December

USD

USA

Adjusted Closing Price for Zai Lab Ltd (ZLAB)

Loading...

Unadjusted Closing Price for Zai Lab Ltd (ZLAB)

Loading...

Share Trading Volume for Zai Lab Ltd Shares

Loading...

Compare Performance of Zai Lab Ltd Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ZLAB

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Zai Lab Ltd (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S -1.36 (-1.05%) USD554.45B 46.01 4.80

ETFs Containing ZLAB

Symbol Name ZLAB's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Zai Lab Ltd (ZLAB) Stock

Based on ratings from 3 analysts Zai Lab Ltd's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on ZLAB's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for ZLAB is USD 62.71 over the next 12 months. The maximum analyst target price is USD 73.34 while the minimum anlayst target price is USD 47.5.

Unfortunately we do not have enough data on ZLAB's stock to indicate if its overvalued.

The last closing price of ZLAB's stock was USD 16.19.

The most recent market capitalization for ZLAB is USD 1.61B.

Based on targets from 3 analysts, the average taret price for ZLAB is projected at USD 62.71 over the next 12 months. This means that ZLAB's stock price may go up by +287.34% over the next 12 months.

We can't find any ETFs which contains Zai Lab Ltd's stock.

As per our most recent records Zai Lab Ltd has 2,175 Employees.

Zai Lab Ltd's registered address is Jinchuang Plaza, Shanghai, China, 201210. You can get more information about it from Zai Lab Ltd's website at https://www.zailaboratory.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...